Skip to main content
Strategic Partners A/S logo

Strategic Partners A/S — Investor Relations & Filings

Ticker · STRAP ISIN · DK0062502894 LEI · 54930025OZD2GGSQ7L42 CO Financial and insurance activities
Open in API
Filings indexed 501 across all filing types
Latest filing 2023-12-08 Major Shareholding Noti…
Country DK Denmark
Listing CO STRAP

About Strategic Partners A/S

https://www.strategic-partners.dk/

Strategic Partners A/S is an investment company that engages in strategic partnerships with businesses that have significant potential. The company's strategy involves taking an active ownership role to create value through its competencies. In addition to its primary focus, the firm may also invest in other equity interests and properties to generate returns. Formerly known as Orphazyme A/S, the company sold its biotechnology activities in May 2022. A new board and management team was appointed in May 2023, and the company officially adopted its new strategy, purpose, and name in October 2024.

Recent filings

Filing Released Lang Actions
Storaktionærmeddelelse
Major Shareholding Notification Classification · 100% confidence The document is titled 'Storaktionærmeddelelse' (Major Shareholder Announcement) and explicitly references Danish capital market laws regarding major shareholding notifications. It details that Scandinavian Investment Group A/S has reduced its stake in Orphazyme A/S to 0%. This fits the definition of a Major Shareholding Notification (MRQ).
2023-12-08 Danish
Transaction in Own Shares 2023
Transaction in Own Shares Classification · 100% confidence The document text is in Danish and the title translates to 'Sale of own shares' ('Salg af egne aktier'). The content explicitly details the sale of 3,212 treasury shares at a specific price (727 DKK per share) and confirms that after the transaction, the company holds no treasury shares. This directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase/issuance). The filing code POS is the correct classification.
2023-12-08 Danish
Salg af egne aktier
Transaction in Own Shares Classification · 100% confidence The document is a company announcement (Selskabsmeddelelse) from Orphazyme A/S regarding the sale of its own shares (treasury shares). It details the quantity of shares sold (3,212), the price per share (727 DKK), and confirms that the company holds no more treasury shares after this transaction. This fits the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or the sale/disposal of treasury shares.
2023-12-08 Danish
Share Issue/Capital Change 2023
Share Issue/Capital Change Classification · 99% confidence The document is titled 'Selskabsmeddelelse 23/2023' (Company Announcement 23/2023) from Orphazyme A/S and details the result of a reverse stock split ('omvendt aktiesplit'). This action directly involves a change in the company's capital structure (converting 1,000 old shares to 1 new share, resulting in the company acquiring its own shares). This fits the definition of 'Share Issue/Capital Change' (SHA) or potentially 'Transaction in Own Shares' (POS). Since the core event is the structural change resulting from the reverse split and the subsequent acquisition of own shares, SHA is the most appropriate primary classification, as it addresses the capital structure modification. The document is a formal announcement of this corporate action.
2023-12-08 Danish
Resultat af omvendt aktiesplit
Share Issue/Capital Change Classification · 98% confidence The document describes the outcome of a reverse stock split process, detailing the conversion ratio, the redemption of fractional shares, and the resulting changes to the share capital and the company's own shareholdings. This falls under the category of capital changes and share structure adjustments. While it mentions a 'Vedhæftet fil' (attached file), the text itself provides the substantive details of the corporate action rather than just announcing the availability of a separate report. Therefore, it is classified as a Share Issue/Capital Change announcement.
2023-12-08 Danish
Share Issue/Capital Change 2023
Share Issue/Capital Change Classification · 99% confidence The document is a 'Business update October 2023' from Orphazyme A/S, dated November 8, 2023. It discusses financial performance (net loss, cash position), corporate actions like a decided reverse stock split, and plans to call an extraordinary general meeting to propose lowering the nominal share value to reestablish share capital as required by the Danish Company Act (due to losses exceeding 50% of share capital). This content relates to capital structure changes, financing options, and upcoming shareholder votes/proposals. It is not a full Annual Report (10-K), a formal Earnings Release (ER) focusing only on highlights, or a standard Interim Report (IR). Since it details proposals for capital structure changes (reducing nominal value, divesting shares from a reverse split) and mentions calling an EGM for a proposal, it strongly aligns with Capital/Financing Update (CAP) or potentially Share Issue/Capital Change (SHA). Given the focus on strengthening the capital structure via nominal value reduction and addressing statutory capital requirements, 'Capital/Financing Update' (CAP) is the most appropriate fit, as it encompasses these structural financing maneuvers.
2023-11-08 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.